Novartis Corporation
Pharmaceutical company
Based in DC
AI Overview
With $80K in lobbying spend across 15 quarterly filings, Novartis Corporation is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $0 |
| 2020 | $0 |
| 2021 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Novartis Corporation disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, MED, Health Issues
Issues related to coverage and reimbursement of pharmaceuticals
Issues related to coverage and reimbursement of pharmaceuticals.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.